These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
253 related items for PubMed ID: 7656667
1. Preliminary study of the in vitro activity of irloxacin against mycobacteria. Casal M, Gutierrez J, Ruiz P, Moreno G. Chemotherapy; 1995; 41(3):204-7. PubMed ID: 7656667 [Abstract] [Full Text] [Related]
2. In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria. Texier-Maugein J, Mormède M, Fourche J, Bébéar C. Eur J Clin Microbiol; 1987 Oct; 6(5):584-6. PubMed ID: 3125050 [Abstract] [Full Text] [Related]
3. [In vitro determination of the sensitivity of mycobacteria to fluoroquinolones]. Dailloux M, Petitpain N, Henry C, Weber M. Pathol Biol (Paris); 1989 May; 37(5):346-9. PubMed ID: 2780092 [Abstract] [Full Text] [Related]
4. Comparative in-vitro activity of five fluoroquinolones against mycobacteria. Davies S, Sparham PD, Spencer RC. J Antimicrob Chemother; 1987 May; 19(5):605-9. PubMed ID: 3112094 [Abstract] [Full Text] [Related]
6. Comparative in-vitro activities of ten fluoroquinolones and fusidic acid against Mycobacterium spp. Van Caekenberghe D. J Antimicrob Chemother; 1990 Sep; 26(3):381-6. PubMed ID: 2228828 [Abstract] [Full Text] [Related]
9. [In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains]. Thomas L, Naumann P, Crea A. Immun Infekt; 1986 Nov; 14(6):203-7. PubMed ID: 3100424 [Abstract] [Full Text] [Related]
10. MICs and MBCs of Win 57273 against Mycobacterium avium and M. tuberculosis. Heifets LB, Lindholm-Levy PJ. Antimicrob Agents Chemother; 1990 May; 34(5):770-4. PubMed ID: 2113793 [Abstract] [Full Text] [Related]
11. Activity of ciprofloxacin against Mycobacteria in vitro: comparison of BACTEC and macrobroth dilution methods. Trimble KA, Clark RB, Sanders WE, Frankel JW, Cacciatore R, Valdez H. J Antimicrob Chemother; 1987 May; 19(5):617-22. PubMed ID: 3112096 [Abstract] [Full Text] [Related]
12. In-vitro activity of quinolones and macrolides against mycobacteria. Yew WW, Piddock LJ, Li MS, Lyon D, Chan CY, Cheng AF. J Antimicrob Chemother; 1994 Sep; 34(3):343-51. PubMed ID: 7829409 [Abstract] [Full Text] [Related]
13. [Comparison of in vitro antimicrobial activities of ofloxacin, levofloxacin, ciprofloxacin, and sparfloxacin against various mycobacteria]. Kawahara S, Tada A, Nagare H. Kekkaku; 2001 Apr; 76(4):357-62. PubMed ID: 11398326 [Abstract] [Full Text] [Related]
14. In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones. Casal M, Rodriguez F, Villalba R, Benavente MC, Gonzalez AI. Chemioterapia; 1987 Dec; 6(6):431-3. PubMed ID: 3481302 [Abstract] [Full Text] [Related]
16. Activity of five fluoroquinolones against Mycobacterium avium-intracellulare complex and M. xenopi. Rastogi N, Goh KS, David HL. Ann Inst Pasteur Microbiol; 1988 Dec; 139(2):233-7. PubMed ID: 3165641 [No Abstract] [Full Text] [Related]
20. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis. Foroumadi A, Soltani F, Moshafi MH. Boll Chim Farm; 2002 Dec; 141(5):394-6. PubMed ID: 12481384 [Abstract] [Full Text] [Related] Page: [Next] [New Search]